{"transactions":[{"id":1056126,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-26T22:11:37.000Z","date":"2025-08-22","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of performance stock which vested on August 22, 2025"}],"balance_after":426554,"source":{"system":"sec-edgar","filing":"0000912282-25-000910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000091228225000910/form4.xml","form_type":"4"}},{"id":1106839,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-18T22:18:00.000Z","date":"2025-06-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":14.0099,"value":700495.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 and $14.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above."}],"balance_after":339554,"source":{"system":"sec-edgar","filing":"0000912282-25-000692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000091228225000692/form4.xml","form_type":"4"}},{"id":1106838,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-18T22:18:00.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":13.0926,"value":981945.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.57 and $13.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above."}],"balance_after":389554,"source":{"system":"sec-edgar","filing":"0000912282-25-000692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000091228225000692/form4.xml","form_type":"4"}},{"id":1184724,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:45:31.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of performance stock which vested on March 31, 2025."}],"balance_after":464554,"source":{"system":"sec-edgar","filing":"0000912282-25-000361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000091228225000361/form4.xml","form_type":"4"}},{"id":1213279,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-11T22:03:19.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of performance stock which vested on March 7, 2025."}],"balance_after":389554,"source":{"system":"sec-edgar","filing":"0000912282-25-000281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000091228225000281/form4.xml","form_type":"4"}},{"id":1562412,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-25T17:17:56.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Performance shares vested on March 21, 2024."}],"balance_after":302554,"source":{"system":"sec-edgar","filing":"0001362118-24-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211824000009/primary_doc.xml","form_type":"4"}},{"id":1830535,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock","published_at":"2023-07-13T16:02:29.000Z","date":"2023-07-11","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement.  In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022.  The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement.  In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022.  The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001362118-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000047/primary_doc.xml","form_type":"4"}},{"id":1830534,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock","published_at":"2023-07-13T16:02:29.000Z","date":"2023-01-27","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock vested on January 27, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock vested on January 27, 2023."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001362118-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000047/primary_doc.xml","form_type":"4"}},{"id":1830533,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-13T16:02:29.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement.  In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022.  The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement.  In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022.  The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement.  In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022.  The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021."}],"balance_after":0,"derivative":{"exercise_price":21.2,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001362118-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000047/primary_doc.xml","form_type":"4"}},{"id":1830532,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-13T16:02:29.000Z","date":"2023-07-11","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":227554,"source":{"system":"sec-edgar","filing":"0001362118-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000047/primary_doc.xml","form_type":"4"}},{"id":1830531,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-13T16:02:29.000Z","date":"2023-07-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement.  In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022.  The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021."}],"balance_after":202554,"source":{"system":"sec-edgar","filing":"0001362118-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000047/primary_doc.xml","form_type":"4"}},{"id":1830530,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-13T16:02:29.000Z","date":"2023-01-27","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77554,"source":{"system":"sec-edgar","filing":"0001362118-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000047/primary_doc.xml","form_type":"4"}},{"id":2423057,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-01-28T19:46:19.000Z","date":"2022-01-27","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 RSUs vested on January 27, 2022.  Of the remaining RSUs, 25,000 vest on January 27, 2023 and 25,000 vest on January 27, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"25,000 RSUs vested on January 27, 2022.  Of the remaining RSUs, 25,000 vest on January 27, 2023 and 25,000 vest on January 27, 2024."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001362118-22-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211822000005/primary_doc.xml","form_type":"4"}},{"id":2423056,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-01-28T19:46:19.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 RSUs vested on January 27, 2022.  Of the remaining RSUs, 25,000 vest on January 27, 2023 and 25,000 vest on January 27, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"25,000 RSUs vested on January 27, 2022.  Of the remaining RSUs, 25,000 vest on January 27, 2023 and 25,000 vest on January 27, 2024."}],"balance_after":75000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001362118-22-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211822000005/primary_doc.xml","form_type":"4"}},{"id":2423055,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-28T19:46:19.000Z","date":"2022-01-27","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52554,"source":{"system":"sec-edgar","filing":"0001362118-22-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211822000005/primary_doc.xml","form_type":"4"}},{"id":2491110,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2021-12-01T15:40:38.000Z","date":"2021-11-30","kind":"purchase","acquired":true,"shares":7831,"price":4.09,"value":32028.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $4.02 to $4.12, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":27554,"source":{"system":"sec-edgar","filing":"0001362118-21-000049","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000049/primary_doc.xml","form_type":"4"}},{"id":2598651,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T18:51:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":343,"price":7.43,"value":2548.49,"ownership":{"direct":true},"balance_after":19723,"source":{"system":"sec-edgar","filing":"0001362118-21-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000029/primary_doc.xml","form_type":"4"}},{"id":2598650,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T18:51:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":63,"price":7.24,"value":456.12,"ownership":{"direct":true},"balance_after":19380,"source":{"system":"sec-edgar","filing":"0001362118-21-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000029/primary_doc.xml","form_type":"4"}},{"id":2598649,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T18:51:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":64,"price":7.29,"value":466.56,"ownership":{"direct":true},"balance_after":19317,"source":{"system":"sec-edgar","filing":"0001362118-21-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000029/primary_doc.xml","form_type":"4"}},{"id":2598648,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T18:51:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":1300,"price":7.26,"value":9438.0,"ownership":{"direct":true},"balance_after":19253,"source":{"system":"sec-edgar","filing":"0001362118-21-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000029/primary_doc.xml","form_type":"4"}},{"id":2598647,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T18:51:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":1297,"price":7.23,"value":9377.31,"ownership":{"direct":true},"balance_after":17953,"source":{"system":"sec-edgar","filing":"0001362118-21-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000029/primary_doc.xml","form_type":"4"}},{"id":2706349,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-19T19:19:00.000Z","date":"2021-05-19","kind":"purchase","acquired":true,"shares":317,"price":8.8073,"value":2791.9141,"ownership":{"direct":true},"balance_after":16656,"source":{"system":"sec-edgar","filing":"0001362118-21-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000010/primary_doc.xml","form_type":"4"}},{"id":2706348,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":76125,"kind":"person","name":"Benathen Marc David","position":1,"cik":"0001845258","reported_name":"Benathen Marc David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-19T19:19:00.000Z","date":"2021-05-19","kind":"purchase","acquired":true,"shares":1099,"price":8.9334,"value":9817.8066,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Jointly held with spouse"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares beneficially owned have been adjusted to reflect an additional 240 shares not previously reported."}],"balance_after":16339,"source":{"system":"sec-edgar","filing":"0001362118-21-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211821000010/primary_doc.xml","form_type":"4"}}]}